{{ variable.name }}
It is used to prevent ischemic stroke in patients with atrial fibrillation. The patients included two categories: 1. Patients with atrial fibrillation with a high risk of stroke (CHA2DS2-VASc score ≥ 2); 2. Patients with non-valvular atrial fibrillation who are not suitable for long-term anticoagulant drug treatment.